Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
1 PT-141 is a relatively new treatment option that is being studied to determine how well it works and what side effects it might have
With companies like Yara making these treatments more accessible through generic options, we're entering a new era where sustainable weight loss and improved metabolic health are within reach for millions of people
CrossRef 65,535 View 3,981 Download 668 Web of Science Crossref Special Issue KASL clinical practice guidelines for management of chronic hepatitis B Endorsed by the East Asia Liver Alliance (EALA) Won-Mook Choi, Ji Won Han, Tae Hyung Kim, Miyoung Choi, Moon Haeng Hur, Hyo Young Lee, Han Ah Lee, Byeong Geun Song, Heechul Nam, Jeong-Ju Yoo, Chang Hun Lee, Gi-Ae Kim, Hye Won Lee, Gwang Hyeon Choi, Young Eun Chon, Yun Bin Lee, Dong Hyun Sinn, Bo Hyun Kim, In Hee Kim, on behalf of the Korean Association for the Study of the Liver (KASL) Clin Mol Hepatol 2026;32(3):1029-1116
Gastroenterology (2009) 137:86572
Accurate dosing depends on accurate measuring, and simpler math means fewer errors
Semaglutide: a medicine to manage type 2 diabetes or treat obesity
US$ 26.67
US$ 27.84
US$ 20.12
US$ 28.22
US$ 24.54
US$ 22.33
US$ 25.01
US$ 22.34
